Outcomes of Antiretroviral Therapy in the Swiss HIV Cohort Study: Latent Class Analysis

被引:0
|
作者
Olivia Keiser
Ben Spycher
Andri Rauch
Alexandra Calmy
Matthias Cavassini
Tracy R. Glass
Dunja Nicca
Bruno Ledergerber
Matthias Egger
机构
[1] University of Bern,Institute of Social and Preventive Medicine (ISPM)
[2] Bern University Hospital and University of Bern,University Clinic for Infectious Diseases
[3] University Hospital Geneva,Division of Infectious Diseases
[4] University Hospital Lausanne,Division of Infectious Diseases
[5] University Hospital Basel,Basel Institute for Clinical Epidemiology and Biostatistics
[6] Cantonal Hospital St.Gallen,Division of Infectious Diseases
[7] University Hospital,Division of Infectious Diseases and Hospital Epidemiology
[8] University of Zürich,undefined
来源
AIDS and Behavior | 2012年 / 16卷
关键词
HIV infection; Antiretroviral therapy; Disease progression; Mortality; Social factors; Behavior; Latent class analysis;
D O I
暂无
中图分类号
学科分类号
摘要
An in-depth understanding of the different groups that make up the HIV-infected population should inform prevention and care. Using latent class analysis (LCA) we identified seven groups with similar socio-demographic and behavioral characteristics at enrolment in the Swiss HIV Cohort Study: older gay men, younger gay men, older heterosexual men, injection drug users, single migrants, migrant women in partnerships and heterosexual men and women. Outcomes of combination antiretroviral therapy (ART) were analyzed in 1,633 patients starting ART. Compared to older gay men, the probability of a virologic response to ART was reduced in single migrants, in older heterosexual men and in IDUs. Loss to follow-up was higher in single migrants and IDUs, and mortality was increased in older heterosexual men and IDUs. Socio-behavioral groups identified by LCA allow insights above what can be gleaned from traditional transmission groups, and may identify patients who could benefit from targeted interventions.
引用
下载
收藏
页码:245 / 255
页数:10
相关论文
共 50 条
  • [1] Outcomes of Antiretroviral Therapy in the Swiss HIV Cohort Study: Latent Class Analysis
    Keiser, Olivia
    Spycher, Ben
    Rauch, Andri
    Calmy, Alexandra
    Cavassini, Matthias
    Glass, Tracy R.
    Nicca, Dunja
    Ledergerber, Bruno
    Egger, Matthias
    AIDS AND BEHAVIOR, 2012, 16 (02) : 245 - 255
  • [2] Hyperlactatemia and antiretroviral therapy: The Swiss HIV Cohort Study
    Boubaker, K
    Flepp, M
    Sudre, P
    Furrer, H
    Haensel, A
    Hirschel, B
    Boggian, K
    Chave, JP
    Bernasconi, E
    Egger, M
    Opravil, M
    Rickenbach, M
    Francioli, P
    Telenti, A
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (11) : 1931 - 1937
  • [3] Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study
    Wolbers, M.
    Bucher, H. C.
    Furrer, H.
    Rickenbach, M.
    Cavassini, M.
    Weber, R.
    Schmid, P.
    Bernasconi, E.
    Hirschel, B.
    Battegay, M.
    HIV MEDICINE, 2008, 9 (06) : 397 - 405
  • [4] Association of non-adherence to antiretroviral therapy with cardiovascular outcomes in virologically suppressed persons living with HIV: the Swiss HIV Cohort Study
    Castillo-Mancilla, J.
    Cavassini, M.
    Schneider, M-P
    Furrer, H.
    Calmy, A.
    Battegay, M.
    Scanferla, G.
    Bernasconi, E.
    Gunthard, H.
    Glass, T. R.
    HIV MEDICINE, 2019, 20 : 202 - 202
  • [5] Changes in weight after switching to dolutegravir containing antiretroviral therapy in the Swiss HIV cohort study
    Mugglin, C.
    Calmy, A.
    Guenthard, H.
    Tarr, P.
    Atkinson, A.
    Scherrer, A.
    Cavassini, M.
    Marzolini, C.
    Schmid, P.
    Bernasconi, E.
    Braun, D.
    Wandeler, G.
    Rauch, A.
    HIV MEDICINE, 2019, 20 : 9 - 9
  • [6] Gender inequalities in the response to combination antiretroviral therapy over time: the Swiss HIV Cohort Study
    Rosin, C.
    Elzi, L.
    Thurnheer, C.
    Fehr, J.
    Cavassini, M.
    Calmy, A.
    Schmid, P.
    Bernasconi, E.
    Battegay, M.
    HIV MEDICINE, 2015, 16 (05) : 319 - 325
  • [7] Antiretroviral adherence program in HIV patients: a feasibility study in the Swiss HIV Cohort Study
    Isabelle Krummenacher
    Matthias Cavassini
    Olivier Bugnon
    Rebecca Spirig
    Marie P. Schneider
    Pharmacy World & Science, 2010, 32 : 776 - 786
  • [8] Antiretroviral adherence program in HIV patients: a feasibility study in the Swiss HIV Cohort Study
    Krummenacher, Isabelle
    Cavassini, Matthias
    Bugnon, Olivier
    Spirig, Rebecca
    Schneider, Marie P.
    PHARMACY WORLD & SCIENCE, 2010, 32 (06): : 776 - 786
  • [9] Longitudinal Analysis of Patterns and Predictors of Changes in Self-Reported Adherence to Antiretroviral Therapy: Swiss HIV Cohort Study
    Glass, Tracy R.
    Battegay, Manuel
    Cavassini, Matthias
    De Geest, Sabina
    Furrer, Hansjakob
    Vernazza, Pietro L.
    Hirschel, Bernard
    bernasconi, Enos
    Rickenbach, Martin
    Gunthard, Huldrych F.
    Bucher, Heiner C.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 54 (02) : 197 - 203
  • [10] Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study
    Weber, R.
    Huber, M.
    Battegay, M.
    Staehelin, C.
    Batanjer, E. Castro
    Calmy, A.
    Bregenzer, A.
    Bernasconi, E.
    Schoeni-Affolter, F.
    Ledergerber, B.
    HIV MEDICINE, 2015, 16 (03) : 137 - 151